You are here

Article Text

Article menu
Download PDFPDF
PostScript
Featured correspondence
The comparison of biomarkers with clinically determined risk
  1. Jin-Ho Choi1,2,
  2. Eun-Seok Jeon1
  1. 1 Department of Medicine, Cardiovascular Imaging Center, Cardiac and Vascular Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  2. 2Department of Emergency Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  1. Correspondence to Jin-Ho Choi, Irwon-Dong 50 Gangnam-Ku, Seoul 135-710, Republic of Korea; choijinh{at}skku.edu

http://dx.doi.org/10.1136/hrt.2010.198598

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The Authors' reply: We thank Dr Adnan Nadir for thoughtful comments on our study.1 We agree with the author that not only the additive role of biomarkers (represented as N-terminal prohormone brain natriuretic peptide, NT-proBNP, or C reactive protein, CRP) …

    View Full Text

    Footnotes

    • Linked articles 198580.

    • Competing interests None.

    • Provenance and peer review Commissioned; not externally peer reviewed.

    Linked Articles